why novartis� landmark cancer drug approval is great news for bluebird
.
�we have waited a long time and we cannot possibly wait any longer.�
.
boston cio of the year® orbie® awards
.
scottish widows has its eyes on the master trust prize
.
our partners
.
he added: �these findings show that despite the tireless work of doctors and nurses, it appears that some cancer patients are still enduring shockingly long waits to start treatment.
.
orchid pharma faces liquidation as lenders reject resolution plan
eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
. nightlife: bot wednesdays, belfast - may 16 2018 [photos]
.
.
.
he described the failure to send the patient for a ct scan on her hip as another "missed opportunity".
.